BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29463935)

  • 1. A20 (TNFAIP3) Alterations in Primary Intestinal Diffuse Large B-cell Lymphoma.
    Fujii M; Takata K; Chuang SS; Miyata-Takata T; Ando M; Sato Y; Yoshino T
    Acta Med Okayama; 2018 Feb; 72(1):23-30. PubMed ID: 29463935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features of 49 primary gastrointestinal diffuse large B-cell lymphoma cases; comparison with location, cell-of-origin, and frequency of MYD88 L265P.
    Nagakita K; Takata K; Taniguchi K; Miyata-Takata T; Sato Y; Tari A; Ohnishi N; Noujima-Harada M; Omote S; Nakamura N; Iwamuro M; Maeda Y; Okada H; Tanimoto M; Yoshino T
    Pathol Int; 2016 Aug; 66(8):444-52. PubMed ID: 27439595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment.
    Paik JH; Go H; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    Leuk Lymphoma; 2013 Sep; 54(9):1934-41. PubMed ID: 23327292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
    Liu F; Zheng JP; Wang L; Zhao DH; Li MY; Wang YM; Liu Y; Ma J; Zeng NY; Liu HX; Liang R; Guo SP; Wang Z; Yan QG
    Am J Clin Pathol; 2019 Jul; 152(2):243-252. PubMed ID: 31140551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher incidence of the SNP Met 788 Ile in the coding region of A20 in diffuse large B cell lymphomas.
    Wenzl K; Hofer S; Troppan K; Lassnig M; Steinbauer E; Wiltgen M; Zulus B; Renner W; Beham-Schmid C; Neumeister P; Deutsch A
    Tumour Biol; 2016 Apr; 37(4):4785-9. PubMed ID: 26518771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
    Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M
    Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic implications of TNFAIP3/A20 deletions in extranodal NK/T-cell lymphoma.
    Ahn H; Yang JM; Jeon YK; Paik JH
    Genes Chromosomes Cancer; 2018 May; 57(5):231-239. PubMed ID: 29380463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features.
    Liu Y; Yu K; Li M; Zeng K; Wei J; Li X; Liu Y; Zhao D; Fan L; Yu Z; Wang Y; Li Z; Zhang W; Bai Q; Yan Q; Guo Y; Wang Z; Guo S
    Hum Pathol; 2017 Jun; 64():213-221. PubMed ID: 28438623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A20 promoted the phagocytosis of lymphoma cells by dendritic cells from activated B-cell-like non-Hodgkin lymphoma.
    Ha NT; Trang DT; Nhat PV; Huong PT; Giang NH; Mao CV; Binh VD; Vuong NB; Xuan NT
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):1-9. PubMed ID: 38814241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
    Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
    Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of TNFAIP3 enhances MYD88
    Wenzl K; Manske MK; Sarangi V; Asmann YW; Greipp PT; Schoon HR; Braggio E; Maurer MJ; Feldman AL; Witzig TE; Slager SL; Ansell SM; Cerhan JR; Novak AJ
    Blood Cancer J; 2018 Oct; 8(10):97. PubMed ID: 30301877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PMA/IONO affects diffuse large B-cell lymphoma cell growth through upregulation of A20 expression.
    Yang W; Li Y; Li P; Wang L
    Oncol Rep; 2016 Aug; 36(2):1069-75. PubMed ID: 27349720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Cen H; Tan X; Guo B
    PLoS One; 2015; 10(12):e0145037. PubMed ID: 26716984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of diffuse large B-cell lymphoma involving small and large intestines: an analysis of 126 patients.
    Maeshima AM; Taniguchi H; Ito Y; Hatta S; Suzuki T; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
    Int J Hematol; 2019 Sep; 110(3):340-346. PubMed ID: 31187439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology.
    Hirsch B; Grünbaum M; Wagner F; Bi Y; Lucka L; Du MQ; Stein H; Dürkop H
    Histopathology; 2012 May; 60(6B):E19-27. PubMed ID: 22393903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma.
    Dong G; Chanudet E; Zeng N; Appert A; Chen YW; Au WY; Hamoudi RA; Watkins AJ; Ye H; Liu H; Gao Z; Chuang SS; Srivastava G; Du MQ
    Clin Cancer Res; 2011 Mar; 17(6):1440-51. PubMed ID: 21266526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study.
    Xu PP; Zhong HJ; Huang YH; Gao XD; Zhao X; Shen Y; Cheng S; Huang JY; Chen SJ; Wang L; Zhao WL
    EBioMedicine; 2017 Feb; 16():106-114. PubMed ID: 28153771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.
    Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
    Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
    Montesinos-Rongen M; Schmitz R; Brunn A; Gesk S; Richter J; Hong K; Wiestler OD; Siebert R; Küppers R; Deckert M
    Acta Neuropathol; 2010 Oct; 120(4):529-35. PubMed ID: 20544211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.